ELTX
Elicio Therapeutics, Inc. Common Stock
PHARMACEUTICAL PREPARATIONS
Best Pharmaceutical Stocks 2026 →
Elicio Therapeutics (ELTX) Stock: Buy, Sell, or Hold?
$1.63
+0.02 (+1.24%)
▲
5d:
+4.49%
30d:
-7.91%
90d:
-48.25%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (95%)
Quality Score
52/100
Position
OVERSOLD
30-Day Fair Range
$1.59 – $1.90
Position: OVERSOLD
Forward P/E & Valuation
-1.1x
Next 12M consensus est.
Wall Street Target
$13.67
+738.4% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$1.25 / $1.89
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: ELTX shows conflicting indicators. Wait for confirmation before entering.
Get Alerted When ELTX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: ELTX is currently trading at $1.63, which is considered oversold relative to its 30-day fair value range of $1.59 to $1.90.
Technical Outlook: Technically, ELTX is in a strong downtrend. Immediate support is located at $1.25, while resistance sits at $1.89.
Market Sentiment: ELTX scores 64/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $13.67 (+738.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ELTX is in a strong downtrend. Immediate support is located at $1.25, while resistance sits at $1.89.
Market Sentiment: ELTX scores 64/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $13.67 (+738.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$1.59 -
$1.90
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
94.7%
Trading Range & Key Levels
30-Day Trading Range
$1.59 -
$1.90
Current vs Trading Range
OVERSOLD
Support Level
$1.25
Resistance Level
$1.89
Current Trend
Strong Downtrend
Technical data as of
Nov 11, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (64/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 738.4% below Wall St target ($13.67)
- WARNING: Composite score 52/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-1.10
Wall Street Target
$13.67
(+738.4%)
Share ELTX Analysis
Share this live ELTX analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (ELTX)
Neutral
1 Retail Mentions
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Sep 21, 2026
Daily AI digest
AI Retail Discussion Summary:
StockTwits shows 100.0% bullish sentiment towards $ELTX with no recent news articles available.
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 7:38 AM ET
Data refreshes hourly during market hours. Next update: 8:38 AM
Data refreshes hourly during market hours. Next update: 8:38 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ELTX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
30 analysts |
$302 | 55 HOLD |
|
ONC
BeOne Medicines AG |
STRONG BUY
27 analysts |
$438 | 35 SELL |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 50 HOLD |
|
ORIC
Oric Pharmaceuticals Inc |
STRONG BUY
15 analysts |
$22 | 67 BUY |
|
TVTX
Travere Therapeutics Inc |
STRONG BUY
15 analysts |
$75 | 66 BUY |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive ELTX Research Pages
